NEW YORK (GenomeWeb News) – Cell Biosciences has sold one of its protein analysis systems to The University of Manchester, the company said today.
The university will use the system in its Stem Cell and Leukemia Proteomics Laboratory to study how phosphoprotein signaling processes in hematopoietic stem calls are different during leukemia.
The platform is a nanofluidic immunoassay system designed to analyze extremely small biological samples, and it can measure cell signaling proteins reproducibly in numbers as small as 25 cells.
Financial terms of the agreement were not released.